The Experts below are selected from a list of 67590 Experts worldwide ranked by ideXlab platform
Bella T Altura - One of the best experts on this subject based on the ideXlab platform.
-
serum ionized magnesium levels and serum ionized calcium ionized magnesium ratios in women with menstrual migraine
Headache, 2002Co-Authors: Alexander Mauskop, Bella T AlturaAbstract:Objective It has been suggested that magnesium deficiency may play an important role in menstrual migraine and that the serum ionized calcium (ICa2+)/ionized magnesium (IMg2+) ratio is important in migraine headache. Studies were designed to test these hypotheses. Design We prospectively evaluated 270 women seen at a headache clinic and in 61 women with menstrual migraine measured IMg2+, total magnesium, and ICa2+ levels so as to calculate the ICa2+/IMg2+ ratio. Results The incidences of IMg2+ deficiency were 45% during menstrual attacks, 15% during nonmenstrual attacks, 14% during Menstruation without a migraine, and 15% between Menstruations and between migraine attacks. The serum ICa2+ levels were within our reference range, but the ICa2+/IMg2+ ratio was elevated (P Conclusions The high incidence of IMg2+ deficiency and the elevated ICa2+/IMg2+ ratio during menstrual migraine confirm previous suggestions of a possible role for magnesium deficiency in the development of menstrual migraine.
-
Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine.
Headache, 2002Co-Authors: Alexander Mauskop, Bella T AlturaAbstract:Objective.—It has been suggested that magnesium deficiency may play an important role in menstrual migraine and that the serum ionized calcium (ICa2+)/ionized magnesium (IMg2+) ratio is important in migraine headache. Studies were designed to test these hypotheses. Design.—We prospectively evaluated 270 women seen at a headache clinic and in 61 women with menstrual migraine measured IMg2+, total magnesium, and ICa2+ levels so as to calculate the ICa2+/IMg2+ ratio. Results.—The incidences of IMg2+ deficiency were 45% during menstrual attacks, 15% during nonmenstrual attacks, 14% during Menstruation without a migraine, and 15% between Menstruations and between migraine attacks. The serum ICa2+ levels were within our reference range, but the ICa2+/IMg2+ ratio was elevated (P
Alexander Mauskop - One of the best experts on this subject based on the ideXlab platform.
-
serum ionized magnesium levels and serum ionized calcium ionized magnesium ratios in women with menstrual migraine
Headache, 2002Co-Authors: Alexander Mauskop, Bella T AlturaAbstract:Objective It has been suggested that magnesium deficiency may play an important role in menstrual migraine and that the serum ionized calcium (ICa2+)/ionized magnesium (IMg2+) ratio is important in migraine headache. Studies were designed to test these hypotheses. Design We prospectively evaluated 270 women seen at a headache clinic and in 61 women with menstrual migraine measured IMg2+, total magnesium, and ICa2+ levels so as to calculate the ICa2+/IMg2+ ratio. Results The incidences of IMg2+ deficiency were 45% during menstrual attacks, 15% during nonmenstrual attacks, 14% during Menstruation without a migraine, and 15% between Menstruations and between migraine attacks. The serum ICa2+ levels were within our reference range, but the ICa2+/IMg2+ ratio was elevated (P Conclusions The high incidence of IMg2+ deficiency and the elevated ICa2+/IMg2+ ratio during menstrual migraine confirm previous suggestions of a possible role for magnesium deficiency in the development of menstrual migraine.
-
Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine.
Headache, 2002Co-Authors: Alexander Mauskop, Bella T AlturaAbstract:Objective.—It has been suggested that magnesium deficiency may play an important role in menstrual migraine and that the serum ionized calcium (ICa2+)/ionized magnesium (IMg2+) ratio is important in migraine headache. Studies were designed to test these hypotheses. Design.—We prospectively evaluated 270 women seen at a headache clinic and in 61 women with menstrual migraine measured IMg2+, total magnesium, and ICa2+ levels so as to calculate the ICa2+/IMg2+ ratio. Results.—The incidences of IMg2+ deficiency were 45% during menstrual attacks, 15% during nonmenstrual attacks, 14% during Menstruation without a migraine, and 15% between Menstruations and between migraine attacks. The serum ICa2+ levels were within our reference range, but the ICa2+/IMg2+ ratio was elevated (P
Catriona Macleod - One of the best experts on this subject based on the ideXlab platform.
-
A contemporary phenomenology of Menstruation: Understanding the body in situation and as situation in public health interventions to address Menstruation-related challenges
Women's Studies International Forum, 2017Co-Authors: Lindsay Kelland, Sharli Anne Paphitis, Catriona MacleodAbstract:Abstract Social science and public health research has pointed to, firstly, the challenges women face in terms of the management of Menstruation and, secondly, to the negative symbolic associations made with the menstruating body. This research, however, seldom engages with philosophical issues relating to embodied subjectivity in order to explain and understand the trends noted. In this paper, we attempt to bridge the divide between feminist theory and current research on the Menstruation-related challenges facing women today. We provide a feminist phenomenological account of Menstruation in which women's shared bodily lived experiences of Menstruation—the body as situation—are set within contexts that enable and/or restrain freedom—the body in situation. This account allows us to understand the universal and differentiated aspects of Menstruation and menstrual management, thereby providing a nuanced picture of the interplay between the physical occurrence of Menstruation, the symbolic associations made with Menstruation, and the socio-material, historical and political conditions within which women live. Such an account, we suggest, should inform advocacy around public policy and institutional civic society that promotes the freedom of women to engage in important life projects, and ground public health interventions around Menstruation related challenges.
Mohammad Rasoul Ghadami - One of the best experts on this subject based on the ideXlab platform.
-
Both melatonin and meloxicam improved sleep and pain in females with primary dysmenorrhea—results from a double-blind cross-over intervention pilot study
Archives of Women's Mental Health, 2018Co-Authors: Farahnaz Keshavarzi, Fariba Mahmoudzadeh, Serge Brand, Dena Sadeghi Bahmani, Fariba Akbari, Habibolah Khazaie, Mohammad Rasoul GhadamiAbstract:Up to 25% of ovulating women suffer from primary dysmenorrhea, a condition associated with pain and transient-reduced quality of life, along with greater irritability and impaired sleep. In the present study, we asked whether and if so to what extent melatonin and meloxicam can improve subjective and objective sleep and reduce pain among women with primary dysmenorrhea (PD). To this end, we conducted a double-blind cross-over clinical trial lasting for three menstrual cycles. A total of 14 women (mean age M = 27.5 years) with primary dysmenorrhea took part in the study. At baseline, that is, during the first Menstruation, they completed a visual analogue scale to rate pain; sleep continuity was assessed via actigraphs, and overall sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI). Next, participants were randomly assigned to one of two conditions, either melatonin during the second, and meloxicam during the third Menstruation, or meloxicam during the second, and melatonin during the third Menstruation. Neither participants nor investigators were aware of participants’ study assignment. During the second and third Menstruations, the assessments described above were repeated. At baseline, sleep assessed both objectively and subjectively was impaired, and pain was high. Subjective sleep improved and pain decreased during the second and third Menstruations irrespective of whether melatonin or meloxicam was administered first or second. Likewise, objective sleep efficiency increased and objective sleep latency shortened. The efficacy of melatonin was superior to that of meloxicam. The present pattern of results suggests that both melatonin and meloxicam are suitable to treat pain and PD-related sleep complaints among women with primary dysmenorrhea.
Mojgan Tansaz - One of the best experts on this subject based on the ideXlab platform.
-
comparing the effect of nigella sativa oil soft gel and placebo on oligomenorrhea amenorrhea and laboratory characteristics in patients with polycystic ovarian syndrome a randomized clinical trial
Research Journal of Pharmacognosy, 2020Co-Authors: Seyedeh Atieh Naeimi, Mojgan Tansaz, Homa Hajimehdipoor, Sojdeh SaberAbstract:Background and objectives: Oligo-amenorrhea is one of the most common symptoms in poly cystic ovarian syndrome (PCOS) patients and Nigella sativa is a medicinal plant used in Iranian traditional medicine for the treatment of oligo-amenorrhea. The aim of this study was to evaluate the effect of N. sativa oil on oligo-amenorrhea in patients with PCOS. Methods: This study was a double-blinded placebo-controlled clinical trial conducted on 84 PCOS patients with oligo-amenorrhea. Patients were randomly assigned to intervention and placebo group. They used two soft gel capsules of N. sativa oil (500 mg, each capsule) or placebo at night for sixteen weeks. Four indices were used to assess Menstruation; the interval between Menstruations, duration of Menstruation, the occurrence of Menstruation and the severity of bleeding. The two groups were compared using analysis of covariance. Result: Fifty five patients completed the study (32 patients in N. sativa group and 23 patients in placebo group). The menstrual interval after the study in the intervention group (45 days, 95% CI) was significantly lower than the control group (86 days). The frequency of menstrual cycle in the intervention group (0.79) was significantly higher than the placebo group (0.48). No serious complication was reported in this clinical trial. Conclusion: findings suggest that N. sativa is an alternative treatment and could be useful for menstrual irregularities in women with PCOS. Further studies are recommended to find the exact mechanisms of N. sativa and its different derivatives.
-
assessing the effect of processed nigella sativa on oligomenorrhea and amenorrhea in patients with polycystic ovarian syndrome a pilot study
International Journal of Pharmaceutical Sciences Review and Research, 2018Co-Authors: Sayedeh Atieyeh Naimi, Mojgan Tansaz, Homa Hajimehdipoor, Razieh NabimeybodiAbstract:Objective: The aim of this pilot study was to assess the effect of processed Nigella Sativa (N. Sativa) on oligomenorrhea and amenorrhea in patients with Polycystic Ovarian Syndrome (PCOS). Materials and Methods: Ten women diagnosed with PCOS, having oligo-amenorrhea, participated in this study. The National Institutes of Health (NIH)’s criteria were used for the diagnosis. The patients, between 18 to 38 years old, were treated with 2 g/day of encapsulated processed N. Sativa for 16 weeks. This study compared Menstruation habits before and after the medication. A series of metabolic and hormonal investigations was done at the beginning and the end of the study. Participants did not take any other medications. Monthly visits were done to assess the treatment. The effects of N. Sativa on the menstrual cycle was evaluated by four criteria: Menstruation occurrence, Menstruations intervals, Menstruation severity and Menstruation duration. The blood test results were analyzed using Stata version 13. Results: The average duration of Menstruation and the ratio of cycle per month significantly increased during a 4-month intervention. In contrast, the average menstrual cycle intervals showed a remarkable decrease. 78% with mild Menstruation before the intervention had moderate Menstruation. Serum cholesterol, triglycerides, FBS, insulin, AST, LH and HOMA-IR index were significantly improved after the intervention. Conclusion: This study suggests that treatment with N. Sativa can be considered as a selective treatment in PCOS patients with oligo-amenorrhea, which needs more studies with bigger sample size and control group.
-
Clinical efficacy of Sesamum indicum L. in oligomenorrhea management.
shiraz e medical journal, 2014Co-Authors: M Yavari, Mojgan Tansaz, Safoura Rouholamin, Soodabeh Bioos, Somayeh EsmaeiliAbstract:Results: This pilot study was carried out on 21 individuals with oligomenorrhea, complaining of Menstruation retardation for more than two weeks, admitted to Beheshti Hospital clinic. Patients who had not used hormonal, chemical or herbal drugs and those who were not pregnant or lactating were enrolled and received sesame once daily for seven days orally. Patients were followed for seven weeks after drug use. At the end of the study, 85% of the patients experienced menstrual bleeding after receiving sesame treatment by two weeks. The mean Menstruation period of the individuals before initiating the study and the treatment was 9.8 days, while the mean postponement time after the last patients’ Menstruation, before treatment, was 92 days. Blood flow and pain during Menstruation were not significantly higher than past Menstruation episodes. No untoward side effect was noticed during the clinical trial. The next Menstruation episode follow-up demonstrated that 80% of the patients had Menstruation without using any drugs with a less than two weeks delay. Conclusions: The results demonstrated that Sesamum indicum L. may be an effective choice in inducing Menstruation in women with oligomenorrhea, which has ignorable side effects comparing to the current hormonal therapies. Stronger clinical trials with placebocontrol groups are recommended to strengthen this hypothesis.
